FOLH1 and posterior cortical atrophy: Emmett et al. performed serial [68Ga]-PSMA-11 PET/CT scans at baseline and on days 9, 18, and 28 in 8 men with hormone-sensitive PCa commencing LHRH +/− bicalutamide and 7 men with castration-resistant PCa commencing NHT (enzalutamide or arbiraterone) [46].